ResMed | RMD - 债务利息支出

金融业

USD

USD 8.78B

现金及等价物

USD 1.66B

USD 551.67M

USD 4.06B

USD 1.35B

USD 847.72M

股息收益率

1.04

USD 505.67M

USD 547.48M

10.6K

EPS每股收益

USD 2.86

股本和储备

USD 6.49B

USD 890.98M

债务利息支出

USD 8.79M

USD 59K

USD 404.17M

USD 30.94B

USD 398.73M

USD 925.74M

USD 505.67M

普通股股本

USD 190.83M

21.21

USD 496.15M

USD 1.4B

销售和管理费用

USD 279.8M

USD 911.88M

贸易债权人

USD 273.3M

应收帐款人

USD 998.84M

	债务利息支出	更改		日
Ansell	USD 20.6M		300K	2025-12
Artivion	USD 5.53M		589K	2025-12
AtriCure	USD 1.37M		42K	2025-12
Baxter International	USD 58M		14M	2025-09
Cochlear	AUD 6.3M		3.65M	2025-12
Cooper Companies	USD 22.4M		2M	2025-12
CSL	USD 215M		111M	2025-12
Dexcom	USD 4.2M		500K	2025-12
Edwards Lifesciences	USD 35.9M		2.7M	2025-12
Fisher Paykel Healthcare	NZD 5.5M		700K	2025-12
Globus Medical	USD 5.44B		5.44B	2026-03
Haemonetics	USD 7.4M		190K	2025-12
Idexx Laboratories	USD 7.74M		2.34M	2026-03
Inogen	1.03M		384K	2025-03
Insulet	USD 14.7M		5.5M	2026-03
Integra LifeSciences	USD 22.46M		1.21M	2026-03
Intuitive Surgical	USD 20.11B		58.39B	2026-03
Masimo	USD 6.1M		1.4M	2026-03
Medtronic	USD 181M		0	2025-12
Philips	EUR 83M		26M	2026-03
Ramsay Health Care	AUD 300.6M		15.5M	2025-12
ResMed	USD 8.79M		14.55M	2025-09
Sigma Healthcare	AUD 7.97M		365K	2024-01
Sonic Healthcare	AUD 86.91M		43.94M	2024-12
Steris	USD 14.9M		0	2025-12
Teleflex	USD 25.72M		2.43M	2026-03
Thermo Fisher Scientific	USD 354M		11M	2026-03